3.2699
+0.0999
+(3.20%)
As of 11:47:50 AM EST. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
55,751.0000
52,548.0000
45,563.0000
48,299.0000
41,975.0000
Cost of Revenue
22,971.0000
23,092.0000
24,214.0000
20,588.0000
16,559.0000
Gross Profit
32,780.0000
29,456.0000
21,349.0000
27,711.0000
25,416.0000
Operating Expense
48,180.0000
52,293.0000
61,894.0000
51,778.0000
40,601.0000
Operating Income
-15,400.0000
-22,837.0000
-40,545.0000
-24,067.0000
-15,185.0000
Net Non Operating Interest Income Expense
-1,494.0000
-819.0000
-1,618.0000
-2,609.0000
-2,565.0000
Other Income Expense
--
--
-5,506.0000
16.0000
984.0000
Pretax Income
-16,894.0000
-23,656.0000
-47,669.0000
-26,676.0000
-16,766.0000
Tax Provision
--
33.0000
-282.0000
175.0000
-79.0000
Net Income Common Stockholders
-16,927.0000
-23,689.0000
-47,387.0000
-26,851.0000
-16,687.0000
Diluted NI Available to Com Stockholders
-16,927.0000
-23,689.0000
-47,387.0000
-26,851.0000
-16,687.0000
Basic EPS
-0.94
-1.34
-2.77
-1.68
-1.32
Diluted EPS
-0.94
-1.34
-2.77
-1.68
-1.32
Basic Average Shares
18,055.1140
17,679.4670
17,082.3480
15,972.2560
12,632.7800
Diluted Average Shares
18,055.1140
17,679.4670
17,082.3480
15,972.2560
12,632.7800
Total Operating Income as Reported
-15,400.0000
-22,837.0000
-46,051.0000
-24,067.0000
-15,185.0000
Total Expenses
71,151.0000
75,385.0000
86,108.0000
72,366.0000
57,160.0000
Net Income from Continuing & Discontinued Operation
-16,927.0000
-23,689.0000
-47,387.0000
-26,851.0000
-16,687.0000
Normalized Income
-16,927.0000
-23,689.0000
-41,914.0360
-26,851.0000
-16,687.0000
Interest Income
743.0000
1,516.0000
830.0000
16.0000
--
Interest Expense
2,237.0000
2,335.0000
2,448.0000
2,625.0000
2,565.0000
Net Interest Income
-1,494.0000
-819.0000
-1,618.0000
-2,609.0000
-2,565.0000
EBIT
-14,657.0000
-21,321.0000
-45,221.0000
-24,051.0000
-14,201.0000
EBITDA
-12,841.0000
-19,153.0000
-43,664.0000
-23,103.0000
-13,655.0000
Reconciled Cost of Revenue
22,971.0000
23,092.0000
24,214.0000
20,588.0000
16,559.0000
Reconciled Depreciation
1,816.0000
2,168.0000
1,557.0000
948.0000
546.0000
Net Income from Continuing Operation Net Minority Interest
-16,927.0000
-23,689.0000
-47,387.0000
-26,851.0000
-16,687.0000
Total Unusual Items Excluding Goodwill
--
--
-5,506.0000
--
--
Total Unusual Items
--
--
-5,506.0000
--
--
Normalized EBITDA
-12,841.0000
-19,153.0000
-38,158.0000
-23,103.0000
-13,655.0000
Tax Rate for Calcs
--
0.0002
0.0000
0.0003
0.0000
Tax Effect of Unusual Items
--
--
-33.0360
--
--
12/31/2020 - 9/19/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PFGTF Pacific Edge Limited
0.0614
-50.12%
PMDI Psychemedics Corporation
2.1400
-0.47%
APDN Applied DNA Sciences, Inc.
0.1910
-3.36%
BNR Burning Rock Biotech Limited
6.69
+3.56%
RVTY Revvity, Inc.
120.92
+6.18%
PSNL Personalis, Inc.
5.34
-4.47%
STRR Star Equity Holdings, Inc.
2.2000
-0.45%
AVCR.V Avricore Health Inc.
0.0600
+9.09%
ENZ Enzo Biochem, Inc.
0.6600
-2.94%
OCX OncoCyte Corporation
2.1100
-4.52%